Bifidobacterium Infantis NLS Super Strain for Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The primary purpose of this randomized, double-blinded, placebo-controlled, crossover clinical trial is to evaluate the efficacy of dietary supplementation with Bifidobacterium infantis NLS super strain among celiac disease patients on a gluten-free who have persistent gastrointestinal symptoms.
Epistemonikos ID: ea3cf89d5f70974cadfc553c83e7e6dcbc048f5f
First added on: May 21, 2024